65 results
8-K
EX-99.1
CENBF
Cen Biotech Inc
18 Apr 17
Entry into a Material Definitive Agreement
12:00am
into a forward triangular merger with Eastern Starr the wholly owned subsidiary of Incumaker, Inc. created specifically for the purpose of acquiring CEN … trading on the OTC markets. Easter Starr will continue CEN’s business purpose seeking to expand it further into the global market.
As consideration
CORRESP
CENBF
Cen Biotech Inc
31 Dec 15
Correspondence with SEC
12:00am
and the subsidiary to its shareholders and to the trading markets; (iv) the parent has a valid business purpose for the spin-off; and (v … for the purpose of maintaining control over the company. On January 14, 2014, a majority of voting shares approved a proposed Directors’ resolution to increase
8-K
CENBF
Cen Biotech Inc
19 Apr 21
CEN Biotech Inc. Announces Board and Management Appointments to Support Planned Expansions
5:03pm
. There are advances of $1,179,328 and $1,065,328 to CEN Ukraine as of December 31, 2020 and 2019, respectively, which were made for the purpose of funding … Inc. (“Emergence Global”) as of December 31, 2020. The loan was made for the business purpose of assisting Emergence with operating expenses. Mr. Byrne
8-K
CENBF
Cen Biotech Inc
18 Apr 17
Entry into a Material Definitive Agreement
12:00am
3681, Eastern Starr Biotech, Inc. was created specifically for the purpose of acquiring CEN Biotech, Inc. (See IRS Code Section 368(a)(2)(D) “Forward … traded company trading on the OTC markets. Eastern Starr will continue CEN’s business purpose seeking to expand it further into the global market.As
424B3
0o0oo3eto i0vo
19 Apr 21
Prospectus supplement
5:05pm
8-K
EX-10.1
ymjhov7yhuqk18fvnf
7 Apr 21
Entry into a Material Definitive Agreement
5:00pm
S-1
EX-5.1
4ra0102 oi9dl
19 Jun 20
IPO registration
12:28pm
424B3
zgqo6nza78btmm
12 Mar 21
Prospectus supplement
3:28pm
8-K/A
EX-10.1
83cke7
20 May 20
Financial Statements and Exhibits
2:24pm
8-K
EX-10.1
y3qo1 oymf4lfgx
8 Apr 21
Entry into a Material Definitive Agreement
5:00pm
8-K/A
yrswh3wt
20 May 20
Financial Statements and Exhibits
2:24pm
424B3
km9sqy9d 0ig7kklpq
30 Jun 20
Prospectus supplement
12:34pm
S-1
udf9 mj4qsydo60ia
19 Jun 20
IPO registration
12:28pm
10-K/A
jz27717kgs2n5cscgx6
14 Apr 16
Annual report (amended)
12:00am
8-K
crhhap ud
29 Aug 19
Entry into a Material Definitive Agreement
11:35am